FAQs

Northwestern is collaborating with Deerfield, an investment firm dedicated to advancing healthcare, to accelerate the translation of research in Northwestern faculty laboratories into clinical therapeutics. Lakeside Discovery is a Deerfield company that will support Northwestern’s innovative translational research and leverage Deerfield’s expertise in accelerating state-of-the-art drug development.

Lakeside will fund projects with the aim of establishing novel therapeutics to cure life-altering diseases.

Through Lakeside, Deerfield has committed up to $65 million in initial funding to support promising Northwestern translational research. Deerfield will provide operational support, and may make additional capital investments into spin-off companies that emerge from Lakeside projects and show commercial potential.

Principal Investigators whose full-time employer is Northwestern or who have a faculty appointment at Northwestern and are subject to Northwestern’s policies regarding the conduct of research and ownership of intellectual property.

To submit an application, please contact us directly.

No – We welcome applications from all therapeutic areas.